Multicenter Evaluation of Dynamic Three-Dimensional Magnetic Resonance Myocardial Perfusion Imaging for the Detection of Coronary Artery Disease Defined by Fractional Flow Reserve
暂无分享,去创建一个
Nikolaus Marx | Christiane Kuhl | Eckart Fleck | Eike Nagel | Sebastian Kozerke | Robert Manka | Manish Motwani | Sven Plein | Alexander Gotschy | Sebastian Reinartz | Bernhard Schnackenburg | Lukas Wissmann | Rolf Gebker | E. Fleck | M. Motwani | E. Nagel | B. Schnackenburg | C. Kuhl | S. Plein | S. Kozerke | R. Gebker | R. Manka | R. Jogiya | L. Wissmann | N. Marx | A. Gotschy | M. Niemann | T. Luescher | Roy Jogiya | Michael Frick | Markus Niemann | Thomas F. Luescher | M. Frick | S. Reinartz
[1] P. Boesiger,et al. High resolution three‐dimensional cardiac perfusion imaging using compartment‐based k‐t principal component analysis , 2011, Magnetic resonance in medicine.
[2] P. H. van der Voort,et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. , 1996, The New England journal of medicine.
[3] E. Nagel,et al. Validation of dynamic 3-dimensional whole heart magnetic resonance myocardial perfusion imaging against fractional flow reserve for the detection of significant coronary artery disease. , 2012, Journal of the American College of Cardiology.
[4] Peter Boesiger,et al. Clinical feasibility of accelerated, high spatial resolution myocardial perfusion imaging. , 2010, JACC. Cardiovascular imaging.
[5] D. Berman,et al. Comparison of the Short‐Term Survival Benefit Associated With Revascularization Compared With Medical Therapy in Patients With No Prior Coronary Artery Disease Undergoing Stress Myocardial Perfusion Single Photon Emission Computed Tomography , 2003, Circulation.
[6] B. J. Gersh. Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy , 2009 .
[7] I. Ford,et al. Validation of Magnetic Resonance Myocardial Perfusion Imaging With Fractional Flow Reserve for the Detection of Significant Coronary Heart Disease , 2009, Circulation.
[8] R. Blankstein,et al. Stress myocardial perfusion imaging by CMR provides strong prognostic value to cardiac events regardless of patient's sex. , 2011, JACC. Cardiovascular imaging.
[9] S. Schoenberg,et al. Cardiac magnetic resonance perfusion imaging for the functional assessment of coronary artery disease: a comparison with coronary angiography and fractional flow reserve. , 2006, European heart journal.
[10] B. Schnackenburg,et al. Gender-based prognostic value of pharmacological cardiac magnetic resonance stress testing: head-to-head comparison of adenosine perfusion and dobutamine wall motion imaging , 2012, The International Journal of Cardiovascular Imaging.
[11] Peter Boesiger,et al. k‐t BLAST and k‐t SENSE: Dynamic MRI with high frame rate exploiting spatiotemporal correlations , 2003, Magnetic resonance in medicine.
[12] R. Kwong,et al. Complementary Prognostic Values of Stress Myocardial Perfusion and Late Gadolinium Enhancement Imaging by Cardiac Magnetic Resonance in Patients With Known or Suspected Coronary Artery Disease , 2009, Circulation.
[13] E. Fleck,et al. Magnetic Resonance Perfusion Measurements for the Noninvasive Detection of Coronary Artery Disease , 2003, Circulation.
[14] S. Plein,et al. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial , 2012, The Lancet.
[15] Volkmar Falk,et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Ca , 2014, European heart journal.
[16] M. Robson,et al. Cardiovascular magnetic resonance perfusion imaging at 3-tesla for the detection of coronary artery disease: a comparison with 1.5-tesla. , 2007, Journal of the American College of Cardiology.
[17] Guido Germano,et al. Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy , 2008, Circulation.
[18] Volkmar Falk,et al. Guidelines on Myocardial Revascularization the Task Force on Myocardial Revascularization of the European Society of Cardiology (esc) and the European Association for Cardio-thoracic Surgery (eacts) Developed with the Special Contribution of the European Association for Percutaneous Cardiovascular I , 2022 .
[19] Sebastian Kozerke,et al. Accelerated CMR using zonal, parallel and prior knowledge driven imaging methods , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[20] K. Nayak,et al. Journal of Cardiovascular Magnetic Resonance Open Access Three Dimensional First-pass Myocardial Perfusion Imaging at 3t: Feasibility Study , 2008 .
[21] P. Boesiger,et al. Dynamic contrast‐enhanced myocardial perfusion MRI accelerated with k‐t sense , 2007, Magnetic resonance in medicine.
[22] E. Fleck,et al. High spatial resolution myocardial perfusion imaging during high dose dobutamine/atropine stress magnetic resonance using k-t SENSE. , 2012, International journal of cardiology.
[23] E. Fleck,et al. Comparison of Dobutamine Stress Magnetic Resonance, Adenosine Stress Magnetic Resonance, and Adenosine Stress Magnetic Resonance Perfusion , 2004, Circulation.
[24] Sebastian Kelle,et al. Prognostic Value of Cardiac Magnetic Resonance Stress Tests: Adenosine Stress Perfusion and Dobutamine Stress Wall Motion Imaging , 2007, Circulation.
[25] E. Nagel,et al. Diagnostic performance of noninvasive myocardial perfusion imaging using single-photon emission computed tomography, cardiac magnetic resonance, and positron emission tomography imaging for the detection of obstructive coronary artery disease: a meta-analysis. , 2012, Journal of the American College of Cardiology.
[26] B. Gersh,et al. Angiographic Versus Functional Severity of Coronary Artery Stenoses in the FAME Study: Fractional Flow Reserve Versus Angiography in Multivessel Evaluation , 2011 .
[27] Helmut Baumgartner,et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous , 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[28] E. Nagel,et al. A selection of recent, original research papers , 2014, Journal of Nuclear Cardiology.
[29] J. Schwitter,et al. Superior diagnostic performance of perfusion-cardiovascular magnetic resonance versus SPECT to detect coronary artery disease: The secondary endpoints of the multicenter multivendor MR-IMPACT II (Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coronary Artery Disease Trial) , 2012, Journal of Cardiovascular Magnetic Resonance.
[30] M. Pencina,et al. Stress Cardiac Magnetic Resonance Imaging Provides Effective Cardiac Risk Reclassification in Patients With Known or Suspected Stable Coronary Artery Disease , 2013, Circulation.
[31] Kay Nehrke,et al. k‐t PCA: Temporally constrained k‐t BLAST reconstruction using principal component analysis , 2009, Magnetic resonance in medicine.
[32] E. Nagel,et al. High-resolution magnetic resonance myocardial perfusion imaging at 3.0-Tesla to detect hemodynamically significant coronary stenoses as determined by fractional flow reserve. , 2011, Journal of the American College of Cardiology.
[33] Uwe Siebert,et al. Clinical ResearchInterventional CardiologyFractional Flow Reserve Versus Angiography for Guiding Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease: 2-Year Follow-Up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) Study , 2010 .
[34] J. Schwitter,et al. MR-IMPACT II: Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coronary artery disease Trial: perfusion-cardiac magnetic resonance vs. single-photon emission computed tomography for the detection of coronary artery disease: a comparative multicentre, multivendor trial. , 2013, European heart journal.
[35] Jane Nixon,et al. Comparison of Cardiovascular Magnetic Resonance and Single-Photon Emission Computed Tomography in Women With Suspected Coronary Artery Disease From the Clinical Evaluation of Magnetic Resonance Imaging in Coronary Heart Disease (CE-MARC) Trial , 2014, Circulation.
[36] A. van Rossum,et al. MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. , 2008, European heart journal.
[37] E. Fleck,et al. Dynamic 3-dimensional stress cardiac magnetic resonance perfusion imaging: detection of coronary artery disease and volumetry of myocardial hypoenhancement before and after coronary stenting. , 2011, Journal of the American College of Cardiology.
[38] Peter Boesiger,et al. Whole-heart dynamic three-dimensional magnetic resonance perfusion imaging for the detection of coronary artery disease defined by fractional flow reserve: determination of volumetric myocardial ischaemic burden and coronary lesion location. , 2012, European heart journal.